New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
Background: Focal segmental glomerulosclerosis (FSGS) is a kidney disease that is commonly associated with proteinuria and the progressive loss of renal function, which is characterized by podocyte injury and the depletion and collapse of glomerular capillary segments. The pathogenesis of FSGS has n...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2018-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2666;epage=2675;aulast=Song |
_version_ | 1811331478546546688 |
---|---|
author | Cheng-Cheng Song Quan Hong Xiao-Dong Geng Xu Wang Shu-Qiang Wang Shao-Yuan Cui Man-Di Guo Ou Li Guang-Yan Cai Xiang-Mei Chen Di Wu |
author_facet | Cheng-Cheng Song Quan Hong Xiao-Dong Geng Xu Wang Shu-Qiang Wang Shao-Yuan Cui Man-Di Guo Ou Li Guang-Yan Cai Xiang-Mei Chen Di Wu |
author_sort | Cheng-Cheng Song |
collection | DOAJ |
description | Background: Focal segmental glomerulosclerosis (FSGS) is a kidney disease that is commonly associated with proteinuria and the progressive loss of renal function, which is characterized by podocyte injury and the depletion and collapse of glomerular capillary segments. The pathogenesis of FSGS has not been completely elucidated; however, recent advances in molecular genetics have provided increasing evidence that podocyte structural and functional disruption is central to FSGS pathogenesis. Here, we identified a patient with FSGS and aimed to characterize the pathogenic gene and verify its mechanism.
Methods: Using next-generation sequencing and Sanger sequencing, we screened the causative gene that was linked to FSGS in this study. The patient's total blood RNA was extracted to validate the messenger RNA (mRNA) expression of coenzyme Q10 monooxygenase 6 (COQ6) and validated it by immunohistochemistry. COQ6 knockdown in podocytes was performed in vitro with small interfering RNA, and then, F-actin was determined using immunofluorescence staining. Cell apoptosis was evaluated by flow cytometry, the expression of active caspase-3 was determined by Western blot, and mitochondrial function was detected by MitoSOX.
Results: Using whole-exome sequencing and Sanger sequencing, we screened a new causative gene, COQ6, NM_182480: exon1: c.G41A: p.W14X. The mRNA expression of COQ6 in the proband showed decreased. Moreover, the expression of COQ6, which was validated by immunohistochemistry, also had the same change in the proband. Finally, we focused on the COQ6 gene to clarify the mechanism of podocyte injury. Flow cytometry showed significantly increased in apoptotic podocytes, and Western blotting showed increases in active caspase-3 in si-COQ6 podocytes. Meanwhile, reactive oxygen species (ROS) levels were increased and F-actin immunofluorescence was irregularly distributed in the si-COQ6 group.
Conclusions: This study reported a possible mechanism for FSGS and suggested that a new mutation in COQ6, which could cause respiratory chain defect, increase the generation of ROS, destroy the podocyte cytoskeleton, and induce apoptosis. It provides basic theoretical basis for the screening of FSGS in the future. |
first_indexed | 2024-04-13T16:21:04Z |
format | Article |
id | doaj.art-b569ae70bc7a42ba9b1727afc520c30a |
institution | Directory Open Access Journal |
issn | 0366-6999 2542-5641 |
language | English |
last_indexed | 2024-04-13T16:21:04Z |
publishDate | 2018-01-01 |
publisher | Wolters Kluwer |
record_format | Article |
series | Chinese Medical Journal |
spelling | doaj.art-b569ae70bc7a42ba9b1727afc520c30a2022-12-22T02:39:56ZengWolters KluwerChinese Medical Journal0366-69992542-56412018-01-01131222666267510.4103/0366-6999.245158New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis PatientCheng-Cheng SongQuan HongXiao-Dong GengXu WangShu-Qiang WangShao-Yuan CuiMan-Di GuoOu LiGuang-Yan CaiXiang-Mei ChenDi WuBackground: Focal segmental glomerulosclerosis (FSGS) is a kidney disease that is commonly associated with proteinuria and the progressive loss of renal function, which is characterized by podocyte injury and the depletion and collapse of glomerular capillary segments. The pathogenesis of FSGS has not been completely elucidated; however, recent advances in molecular genetics have provided increasing evidence that podocyte structural and functional disruption is central to FSGS pathogenesis. Here, we identified a patient with FSGS and aimed to characterize the pathogenic gene and verify its mechanism. Methods: Using next-generation sequencing and Sanger sequencing, we screened the causative gene that was linked to FSGS in this study. The patient's total blood RNA was extracted to validate the messenger RNA (mRNA) expression of coenzyme Q10 monooxygenase 6 (COQ6) and validated it by immunohistochemistry. COQ6 knockdown in podocytes was performed in vitro with small interfering RNA, and then, F-actin was determined using immunofluorescence staining. Cell apoptosis was evaluated by flow cytometry, the expression of active caspase-3 was determined by Western blot, and mitochondrial function was detected by MitoSOX. Results: Using whole-exome sequencing and Sanger sequencing, we screened a new causative gene, COQ6, NM_182480: exon1: c.G41A: p.W14X. The mRNA expression of COQ6 in the proband showed decreased. Moreover, the expression of COQ6, which was validated by immunohistochemistry, also had the same change in the proband. Finally, we focused on the COQ6 gene to clarify the mechanism of podocyte injury. Flow cytometry showed significantly increased in apoptotic podocytes, and Western blotting showed increases in active caspase-3 in si-COQ6 podocytes. Meanwhile, reactive oxygen species (ROS) levels were increased and F-actin immunofluorescence was irregularly distributed in the si-COQ6 group. Conclusions: This study reported a possible mechanism for FSGS and suggested that a new mutation in COQ6, which could cause respiratory chain defect, increase the generation of ROS, destroy the podocyte cytoskeleton, and induce apoptosis. It provides basic theoretical basis for the screening of FSGS in the future.http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2666;epage=2675;aulast=SongApoptosis; Coenzyme Q10 Monooxygenase 6 Mutation; Focal Segmental Glomerulosclerosis; Podocyte |
spellingShingle | Cheng-Cheng Song Quan Hong Xiao-Dong Geng Xu Wang Shu-Qiang Wang Shao-Yuan Cui Man-Di Guo Ou Li Guang-Yan Cai Xiang-Mei Chen Di Wu New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient Chinese Medical Journal Apoptosis; Coenzyme Q10 Monooxygenase 6 Mutation; Focal Segmental Glomerulosclerosis; Podocyte |
title | New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient |
title_full | New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient |
title_fullStr | New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient |
title_full_unstemmed | New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient |
title_short | New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient |
title_sort | new mutation of coenzyme q10 monooxygenase 6 causing podocyte injury in a focal segmental glomerulosclerosis patient |
topic | Apoptosis; Coenzyme Q10 Monooxygenase 6 Mutation; Focal Segmental Glomerulosclerosis; Podocyte |
url | http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2666;epage=2675;aulast=Song |
work_keys_str_mv | AT chengchengsong newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT quanhong newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT xiaodonggeng newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT xuwang newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT shuqiangwang newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT shaoyuancui newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT mandiguo newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT ouli newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT guangyancai newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT xiangmeichen newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient AT diwu newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient |